Kamar N - Search Results

1

Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective.

Alric L, Ollivier-Hourmand I, Bérard E, Hillaire S, Guillaume M, Vallet-Pichard A, Bernard-Chabert B, Loustaud-Ratti V, Bourlière M, de Ledinghen V, Fouchard-Hubert I, Canva V, Minello A, Nguyen-Khac E, Leroy V, Saadoun D, Trias D, Pol S, Kamar N. Alric L, et al. Among authors: kamar n. Kidney Int. 2018 Jul;94(1):206-213. doi: 10.1016/j.kint.2018.02.019. Epub 2018 May 5. Kidney Int. 2018. PMID: 29735308 Free article.

2

Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology.

Kamar N, Sandres-Saune K, Selves J, Ribes D, Cointault O, Durand D, Izopet J, Rostaing L. Kamar N, et al. Am J Kidney Dis. 2003 Jul;42(1):184-92. doi: 10.1016/s0272-6386(03)00422-0. Am J Kidney Dis. 2003. PMID: 12830471 Clinical Trial.

3

Ureteral stenosis as the sole manifestation of Wegener's granulomatosis.

Kamar N, Malavaud B, Alric L, le Mao G, Mazerolles C, Duffaut M, Sarramon JP, Pourrat J. Kamar N, et al. Urology. 2003 Aug;62(2):352. doi: 10.1016/s0090-4295(03)00368-6. Urology. 2003. PMID: 12893360

4

Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function.

Kamar N, Chatelut E, Manolis E, Lafont T, Izopet J, Rostaing L. Kamar N, et al. Am J Kidney Dis. 2004 Jan;43(1):140-6. doi: 10.1053/j.ajkd.2003.09.019. Am J Kidney Dis. 2004. PMID: 14712437

5

[Hepatitis C virus and renal transplantation].

Kamar N, Rostaing L, Alric L. Kamar N, et al. Gastroenterol Clin Biol. 2004 Feb;28(2):120-5. doi: 10.1016/s0399-8320(04)94864-6. Gastroenterol Clin Biol. 2004. PMID: 15060455 Free article. Review. French. No abstract available.

6

Convenient biological assay for polyethylene glycol-interferons in patients with hepatitis C.

Boulestin A, Kamar N, Legrand-Abravanel F, Sandres-Saune K, Alric L, Vinel JP, Rostaing L, Izopet J. Boulestin A, et al. Among authors: kamar n. Antimicrob Agents Chemother. 2004 Sep;48(9):3610-2. doi: 10.1128/AAC.48.9.3610-3612.2004. Antimicrob Agents Chemother. 2004. PMID: 15328140 Free PMC article.

7

Natural history of hepatitis C virus-related liver fibrosis after renal transplantation.

Kamar N, Rostaing L, Selves J, Sandres-Saune K, Alric L, Durand D, Izopet J. Kamar N, et al. Am J Transplant. 2005 Jul;5(7):1704-12. doi: 10.1111/j.1600-6143.2005.00918.x. Am J Transplant. 2005. PMID: 15943629 Free article.

8

Lack of evidence for ribavirin monotherapy efficacy on liver fibrosis in hepatitis C virus positive renal transplant patients.

Kamar N, Izopet J, Alric L, Rostaing L. Kamar N, et al. Transplantation. 2005 Jun 27;79(12):1770-1; author reply 1771. doi: 10.1097/01.tp.0000158279.29506.e0. Transplantation. 2005. PMID: 15973189 No abstract available.

9

Intrahepatic cytokine profile in renal-transplant patients infected by hepatitis C virus.

Kamar N, Rostaing L, Sandres-Saune K, Selves J, Barthe C, Dubois M, Alric L, Durand D, Izopet J. Kamar N, et al. J Med Virol. 2005 Aug;76(4):482-8. doi: 10.1002/jmv.20387. J Med Virol. 2005. PMID: 15977245

10

Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.

Boulestin A, Kamar N, Sandres-Sauné K, Legrand-Abravanel F, Alric L, Vinel JP, Rostaing L, Izopet J. Boulestin A, et al. Among authors: kamar n. J Med Virol. 2006 Mar;78(3):365-71. doi: 10.1002/jmv.20548. J Med Virol. 2006. PMID: 16419107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

755 results

Search Page

Filters